Skip to main content

Table 3 Association between chronic disorders and homebound status in a population testing positive to disability screening

From: Prevalence of and factors associated with homebound status among adults in urban and rural Spanish populations

Disease Disease prevalence
N (%)
OR (95 % CI)a OR (95 % CI)b
Hypertension 372 (47) 0.71 (0.48–1.06) 0.86 (0.52–1.43)
Ischaemic heart disease 68 (9) 0.94 (0.47–1.88) 1.18 (0.49–2.82)
Arrhythmias 102 (13) 1.16 (0.69–1.96) 0.87 (0.44–1.74)
Heart failure 25 (3) 1.55 (0.61–3.95) 1.04 (0.32–3.38)
Cerebrovascular disease 86 (11) 2.69 (1.56–4.64) 0.84 (0.41–1.70)
Peripheral arterial disease 14 (2) 0.74 (0.15–3.67) 0.57 (0.09–3.42)
COPD 62 (8) 2.23 (1.16–4.29) 1.73 (0.78–3.84)
Asthma 25 (3) 0.95 (0.33–2.77) 0.56 (0.14–2.27)
Diabetes 134 (17) 2.30 (1.44–3.68) 1.87 (1.03–3.41)
Thyroid diseases 75 (9) 0.87 (0.45–1.67) 0.90 (0.37–2.19)
Chronic renal failure 29 (4) 2.94 (1.28–6.77) 1.39 (0.51–3.77)
Chronic liver disease 6 (1) 1.01 (0.10–10.22) 2.55 (0.22–28.96)
Anaemia 33 (4) 0.81 (0.31–2.11) 0.68 (0.22–2.09)
Cancer 42 (5) 2.13 (0.96–4.76) 1.94 (0.68–5.51)
Anxiety disorder 69 (9) 0.49 (0.22–1.10) 0.56 (0.22–1.45)
Depression 140 (18) 2.03 (1.28–3.22) 1.40 (0.78–2.49)
Dementia 47 (6) 3.14 (1.60–6.16) 0.24 (0.09–0.65)
Neurodegenerative diseases and dystrophiesc 17 (2) 3.62 (1.16–11.33) 1.24 (0.30–5.06)
Severe mental disease 8 (1) 7.09 (1.35–37.16) 0.46 (0.05–4.15)
Arthritis or arthrosis 401 (51) 0.96 (0.65–1.41) 1.79 (1.05–3.05)
Hip fracture 13 (2) 2.19 (0.59–8.13) 1.21 (0.17–8.80)
Visual impairment 56 (7) 3.06 (1.64–5.73) 1.53 (0.68–3.46)
Audition impairment 36 (5) 2.35 (1.09–5.07) 1.46 (0.56–3.79)
Urinary incontinence 42 (5) 1.45 (0.71–2.97) 0.64 (0.26–1.59)
  1. COPD chronic obstructive pulmonary disease, CI confidence interval, OR odds ratio
  2. aAdjusted for sex, age group, area (rural/urban), and number of years of formal education
  3. bAdditionally adjusted for number of chronic disorders (excluding index disease), disability (ICF Checklist score, in logarithmic transformation), and cognitive impairment (yes/no) except in dementia
  4. cParkinson’s disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis